Costs and Benefits of Homeless TB Screening in San Francisco

Similar documents
San Francisco Department of Public Health Program Collaboration and Service Integration Surveillance Baseline Assessment

Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines

Management of Patients with TB Infection Catalina Navarro, RN, BSN April 7, 2015

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014

Clinical Practice Guideline

Revised Technical Instructions for Civil Surgeons. October 9, 2018

Case Management of the TB/HIV Infected Patient

LTBI monitoring and evaluation in the Netherlands

The Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer

Accomplishments and Future Directions

Latent TB, TB and the Role of the Health Department

TB Infection Who is Testing and Treating? TB Control and Elimination: Current Dilemma. Span of TB Control: 2010

Shelter Health and Wellness San Francisco DPH. Public Health Nurse Perspective Kathleen Murphy Shuton RN, PHN

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Interpretation of TST & IGRA results. Objectives

These recommendations will remain in effect until the national shortage of PPD solution has abated.

Contact Investigation San Antonio, Texas January 14-15, 2013

SFDPH Responds to Hepatitis C: Strategic Directions for and Beyond

Utilizing All the Tools in the TB Toolbox

TUBERCULOSIS CONTACT INVESTIGATION

Summary Report: Survey of Hepatitis C Virus counseling and testing services at HIV counseling and testing sites, and health service sites.

LTBI: Who to Test & When to Treat

LTBI Treatment and Anti TNF alpha

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

Contact Investigation

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

TB in Corrections Phoenix, Arizona

Pediatric Tuberculosis in Los Angeles County: An Update

TB Classification (ATS/CDC)

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis?

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

Evaluation and Management of the Patient with Latent Tuberculosis Infection (LTBI)

Tuberculosis Populations at Risk

TB Skin Test Practicum Houston, Texas Region 6/5 South September 23, 2014

Integrating Hepatitis Services into HIV Programs: The Local Health Department Perspective

Improving HIV & Hep C Screening and Testing Results. Shikata Mudakha M.D., Physician Lead Armando Rojas, Patient Coordinator

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

Tuberculosis Update. Topics to be Addressed

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium

Nancy Knickerbocker, BA Provider and Community Specialist County of San Diego Immunization Branch Epidemiological and Immunization Services

MEMORANDUM. Re: Guidance for follow-up of newly-arrived Individual with a Class B1 Tuberculosis Extrapulmonary Tuberculosis

MEMORANDUM. Re: Guidance for follow-up of newly-arrived individual with Class B1 Tuberculosis Pulmonary Tuberculosis, no treatment

Management of Pediatric Tuberculosis in New Jersey

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

Essential Mycobacteriology Laboratory Services in the Era of MDR- and XDR-TB: A TB Controller s Perspective

Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings

Racial and Ethnic Approaches to Community Health (REACH) Project

Diagnosis and Medical Management of Latent TB Infection

Tuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013

Latent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal

Protecting and Promoting Health and Equity

Peggy Leslie-Smith, RN

ATTACHMENT 2. New Jersey Department of Health Tuberculosis Program FREQUENTLY ASKED QUESTIONS

INDEX CASE INFORMATION

2017/2018 Annual Volunteer Tuberculosis Notice

5/8/2012 BACKGROUND. Panelists. Session Objectives. Session Agenda. Moving Toward Universal Testing HIV Testing of TB Cases. Jennifer Flood, MD

Approaches to LTBI Diagnosis

HIV SEMI ANNUAL SURVEILLANCE REPORT

Participant Autonomy and HCV Elimination:

TB Contact Investigation

Implementation of testing (and other interventions along the Continuum of Care)

Literature Overview. Health Economics. Experience with QuantiFERON -TB Gold. Cellestis Clinical Guide series

Protocol of National TB Prevalence Survey in Cambodia

Outline. Tuberculosis (TB) Medical Evaluation for TB 5/5/2014. Chest Radiograph with Lower Lobe Cavity

CASTING THE NET TOO WIDE: COLORADO S STI/HIV AND VIRAL HEPATITIS MEDICAID EXPERIENCE

Screening of HIV-Infected Patients with IGRAs for LTBI. Background. Tuberculosis is the most prevalent in the world.

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

Communicable Disease Control Manual Chapter 4: Tuberculosis. Assessment and Follow-Up of TB Contacts

Hepatitis C in Massachusetts Epidemiology and Public Health Response

Please distribute a copy of this information to each provider in your organization.

San Francisco Eligible Metropolitan Area 2013 Summary Report of HIV/AIDS Bureau's Quality Management Performance Measures

HIV SEMI ANNUAL SURVEILLANCE REPORT

HIV SEMI ANNUAL SURVEILLANCE REPORT

Update on the 2007 TB Technical Instructions. Adriene Rister TB Control Coordinator Mainely TB: April 14, 2011

Tuberculosis Intensive

Annual Tuberculosis Report Oregon 2007

TB-Free California: How close are we? How can we get closer?

TB Disease Prevalence Survey - Overview, why and how

Eliminating HCV in San Francisco

Community Health Equity & Promotion (CHEP): Supporting Health Equity in the Tenderloin Neighborhood

Yakima Health District BULLETIN

SAN FRANCISCO WHOLE PERSON CARE Homeless Mortality in San Francisco Opportunities for Prevention

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

LATENT TUBERCULOSIS. Robert F. Tyree, MD

TB Disease Prevalence Survey - Overview and Introduction of the TF

HIV Prevention, Hepatitis Programming, and Drug User Health An Integrated Service Model at SFDPH. Protecting and Promoting Health and Equity

HIV Continuum of Care Connecticut, 2015

Public Health and Corrections: A Model of Program Collaboration and Service Integration (PCSI)

TB Prevention Who and How to Screen

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

VERSION STUDENT. Outbreak of Tuberculosis in a Homeless Men s Shelter. Cases in Population-Oriented Prevention (C-POP)-based teaching cases

San Francisco Eligible Metropolitan Area 2012 Summary Report of HIV/AIDS Bureau's Quality Management Performance Measures

2016 Annual Tuberculosis Report For Fresno County

STD UPDATE Patrick Loose, Chief HIV, STD & Hepatitis Branch February 15, 2018

TB in Corrections Phoenix, Arizona

Transcription:

POPULATION HEALTH DIVISION PROTECTING AND PROMOTING HEALTH AND EQUITY Costs and Benefits of Homeless TB Screening in San Francisco Julie Higashi, MD PhD, TB Controller San Francisco Department of Public Health Disease Prevention and Control Branch April 17, 2014 1

Outline Overview of TB screening of homeless shelter residents in San Francisco TB program-associated costs of homeless screening Benefits of the homeless TB screening program in San Francisco Questions for the future 2

Homeless TB Screening in San Francisco Mandatory TB screening for residents of City-operated shelters began in 2005 Coincided with Widespread adoption of QFT-Gold in SFDPH clinics Implementation of the CHANGES shelter registration system 3

TB & Homeless Task Force Developed in 2000 to Produce Guidelines 4

TB Screening Policy All clients receiving San Francisco shelter services for more than 3 days (cumulative within a 30-day period) are required to complete TB screening and evaluation within 10 working days of entering the shelter system Includes city-operated emergency shelters and resource centers but not private or faith-based shelters 5

Initial Screening Screening Results Follow-up Data Entry TST or QFT negative and asymptomatic TST or QFT+ and asymptomatic Symptomatic None (until following year) Provide green TB clearance card Chest x-ray Medical evaluation at TB Clinic (refer with TB47 form) New chest x-ray Urgent medical evaluation TST or QFT Enter shelter clearance date in the LCR TB Control enters shelter clearance date or clinical alert in the LCR All TB suspects should be sent to TB Clinic for evaluation. If work-up by provider is negative, enter clearance in the LCR LCR = Lifetime Clinical Record, DPH EHR 6

Annual Follow-up Screening Client Type Treatment History Evaluation Required HIV or HIV+ / TST or QFT HIV or HIV unknown/ TST or QFT+ HIV or HIV unknown/ TST or QFT+ HIV+/ TST or QFT+ HIV+/ TST or QFT+ No prior treatment Completed LTBI treatment No prior or incomplete treatment Completed preventive treatment No prior or incomplete treatment Annual TST/QFT Annual symptom review Annual symptom review Annual symptom review and medical risk assessment for diabetes, cancer, immune modulating medication intake, endstage renal disease and HIV If new risk present, repeat chest x- ray annually if patient remains untreated Annual symptom review Low threshold to repeat CXR Minimum annual symptom review and repeat CXR Should be followed by SF TB Control (please refer to TB clinic if necessary) 7

Clearance Shelter client issued a TB clearance card upon completion of screening Expiration date is entered into the DPH Lifetime Clinical Record (LCR) Client presents card to shelter/resource center staff at check-in Expiration date is entered into the CHANGES registration system Date color-coded based on whether clearance is about to expire (orange) or has expired (red) 8

TB Screening and Evaluation Process Client referred to DPH clinic/affiliated clinic for TST/QFT If QFT/TST+ or prior positive or symptomatic, client is referred to TB clinic for chest x-ray and MD evaluation Clearance card given to client At DPH/affiliated clinic if TST/QFT negative (select sites) At TB clinic if TST/QFT+, prior positive, or symptomatic Temporary clearance given as needed 9

TB Program Costs Assumptions 2005-2012 and Estimates (1) Annual average of 1,729 homeless needing screening 1 QFT-Gold In-tube cost 2 : $32.86 (includes labor and supplies) QFT-Gold In-tube positive rate 3 : 7% Chest X-ray and MD visit cost 2 : $82.50 1 San Francisco Human Services Agency. San Francisco Sheltered and Unsheltered Homeless Count. (2009 & 2011) 2 Estimates from unpublished cost effectiveness analysis of QFT in San Francisco. 10 3 San Francisco LTBI rate among homeless persons, 2005-2011.

TB Program Costs Assumptions and Estimates (2) TB Clinic staff time per patient needing chest x-ray and MD evaluation 1 Clerical (registration) 15 minutes Health Worker (registration) 7 min Nurse (provide clearance) 5 min 1 Based on TB Clinic time survey data collected February-March 2012. Time estimates do not include time to draw QFT or refer patient to TB clinic for chest x-ray and evaluation. 11

Annual TB Program Cost QFT-Gold In-tube Test: 1,729 x $32.86 = $56,827 # needing chest x-ray and MD evaluation: 0.07 x 1,729 = 121 Chest X-ray and MD evaluation: 121 x $82.50 = $9,987 TB Clinic staff time: $1,922 Clerical: 30.26 hours x $28.59 = $865 Health Worker: 14.12 hours x $27.69 = $392 Nurse: 18.23 min. x 10.09 hours = $665 TOTAL ANNUAL COST $68,736 12

Homeless Cases, 2005-2013 Year Shelter SRO Street/Other City Private 2005 (n=17) 3 (18%) 0 7 (41%) 7 (41%) 2006 (n=22) 2 (9%) 1 (5%) 11 (50%) 8 (36%) 2007 (n=25) 3 (12%) 1 (4%) 12 (48%) 9 (36%) 2008 (n=15) 3 (20%) 0 5 (33%) 7 (47%) 2009 (n=15) 0 0 6 (40%) 9 (60%) 2010 (n=7) 1 (14%) 1 (14%) 2 (29%) 3 (43%) 2011 (n=11) 4 (36%) 0 5 (46%) 2 (18%) 2012 (n=12) 0 0 8 (67%) 4 ( 33%) 2013 (n=18) 2 0 4 12 Total (n=142) 18 (13%) 3 (2%) 60 (42%) 61 (43%) 13

Characteristics SF City Shelter Cases, 2005-2012 (1) City SRO Shelter Pulm. Smear + 47% 45% Pulm. Culture + 80% 73% Pulm. Cavitary 0 36% HIV + 36% 33% Died 6% 14% 14

Characteristics SF HSA Shelter Cases, 2005-2012 (2) City SRO Shelter Converters 1 8 Clustered Cases 1 0 9 2 1 Clustered to another case in the same shelter or SRO at any time, 2005-2012. 2 Two clusters. 15

Other Benefits (1) Developed close working relationship with homeless providers and shelter staff Facilitates timely response to exposures Opportunities for education and training for shelter staff Brings TB awareness to shelter staff Use CHANGES to target contact investigations Overlapping mechanisms to track screening and clearance TB Control, CHANGES (shelters), LCR (EHR) Addresses the disparity in TB rates among the homeless 16

Other Benefits (2) Screening provides opportunity to link patients to other services HIV, cancer, viral hepatitis, diabetes, mental health services, primary care Indirectly provides screening for clients being transferred from shelters to SRO housing QFT allows for LTBI surveillance in this population Green card is powerful motivation for getting TST read 17

Questions for the future With established relationships and tracking systems Are there opportunities to reduce costs? Reduce frequency of annual screening? How can we expand treatment for LTBI in this population? Use 3HP? Is it cost effective?? Does screening program have an impact on health outcomes? TB? Overall health of the population? 18

Acknowledgements Jennifer Grinsdale, MPH, Public Health Informatics Chief, SFDPH Masae Kawamura, MD Christine Ho, MD Sheila Davis-Jackson, TB Clinic Manager 19